Recombinant expression | CHO cells antibody production | evitria AG

Recombinant expression is one of the most practical ways to produce a high-quality Antibody (and many other recombinant proteins) when you want repeatable results, clear documentation, and the freedom to engineer formats from sequence. Instead of being limited by traditional antibody generation timelines, recombinant workflows let you move from DNA sequence → expressed protein → purification → functional validation in a controlled, traceable way.For many labs and biotech teams, CHO cells (Chinese Hamster Ovary cells) are the preferred host for recombinant antibody production because they support mammalian folding, secretion, and glycosylation—features that can matter a lot for antibody behavior in real assays. Companies such as Evitria AG are known for CHO-based recombinant antibody expression services, helping researchers produce sequence-defined antibodies and other proteins without building a full manufacturing pipeline internally.

This article explains the fundamentals and the practical decisions that matter most—starting with Antibody Basics (including the basic antibody structure and the basic structure of an antibody), then walking through CHO-based expression workflows, quality checkpoints, and best practices. You’ll also see how a research supplier like BetalifeSci can fit naturally into this ecosystem—supporting your work with antibodies, antigens, and recombinant proteins for discovery and validation.

Why CHO-based recombinant expression matters

If your goal is reliable data and consistent reagents, CHO-based recombinant expression offers real advantages:

• Reproducibility: sequence-defined products reduce lot-to-lot variability.
• Speed for discovery: transient expression can supply material quickly for screening and characterization.
• Mammalian-like processing: CHO cells support folding and post-translational modifications relevant to antibodies.
• Engineering flexibility: you can switch constant regions, silence Fc function, create fusions, or test variants without changing your core antigen-binding logic.
• Scalability: CHO systems can support small batches for R&D and larger runs when candidates mature.

Most importantly, recombinant expression gives you a “clean chain of evidence”: the antibody you test is directly connected to the DNA sequence you designed.

Antibody Basics

Before choosing an expression system, it helps to revisit Antibody Basics in the simplest, most useful way.

Basic antibody structure (quick and practical)

A typical IgG antibody is often described as a Y-shaped molecule made of:

• Two heavy chains
• Two light chains

The top of the Y contains the variable regions (VH and VL), which form the antigen-binding site. This is where specificity comes from.

The stem of the Y is the Fc region (constant region). The Fc influences stability, half-life, and interactions with Fc receptors or complement (depending on isotype and context).

Basic structure of antibody: why it matters for production

The basic structure of an antibody matters because recombinant expression usually requires:

• A DNA sequence for the heavy chain
• A DNA sequence for the light chain
• A signal peptide for secretion
• A defined constant region (e.g., IgG1, IgG4, etc.) based on your application
• Once those pieces are defined, you can produce the antibody as a sequence-defined product—one of the biggest strengths of recombinant workflows.

What is a recombinant expression?

Recombinant expression means producing a protein by introducing a designed DNA construct into a host cell so the cell manufactures the protein for you.

In antibody production, this typically includes:

1. Construct design (heavy + light chain genes, promoters, secretion signal)

2. Transfection into host cells

3. Expression culture (cells secrete antibodies into the media)

4. Harvest (collect culture supernatant)

5. Purification (often Protein A for IgG)

6. Quality control (purity, aggregation, identity, binding)

The same overall logic can be used to produce other recombinant proteins, including antigens, receptors, enzymes, cytokines, and fusion proteins.

Why CHO cells are a go-to host for antibody production

CHO cells are widely used because they combine practical scalability with mammalian protein processing. For antibodies, that means:

• Correct folding and disulfide bond formation
• Efficient secretion into culture medium
• Glycosylation patterns appropriate for many antibody applications
• Good compatibility with engineered antibody formats

In plain terms, CHO expression often produces antibodies that behave predictably in real biological and analytical conditions.

CHO cells antibody production: transient vs stable expression

One of the most important strategic decisions is whether you need transient or stable expression.

Transient CHO expression

Transient expression introduces DNA into CHO cells temporarily.

Best when you want:

• Fast turnaround for screening
• Multiple variants are tested quickly
• Early discovery material for binding/functional assays

What to keep in mind:

• Great for speed and flexibility
• Batch-to-batch consistency is achievable with good process control

Stable CHO expression

Stable expression integrates or maintains the construct so that cells produce the antibody over a longer time.

Best when you want:

• Larger quantities over repeated runs
• Stronger long-term consistency for lead candidates
• A clearer bridge toward manufacturing-like workflows

What to keep in mind:

• Takes longer to establish compared to transient expression
• Often chosen when a candidate is “promoted” from screening to deeper development

A common, efficient path is: transient for rapid evaluation → stable for scaled supply.

Where Evitria AG fits in CHO-based recombinant expression

Many teams choose a specialized partner when they want CHO-based production without building a full infrastructure.

Evitria AG positions itself as a CHO-based recombinant antibody expression provider, supporting recombinant antibody production and other proteins using optimized CHO expression platforms.

Working with a specialist can be especially helpful when you need:

• Quick, reliable execution for multiple antibody variants
• Support for engineered formats (depending on the project)
• Purification and QC packaged with expression
• Extra capacity during peak workloads

The value is simple: you stay focused on your biology and decision-making, while the expression workflow is handled with dedicated expertise.

Step-by-step: how CHO recombinant antibody production typically works

Below is a practical, end-to-end view of CHO-based production from sequence to purified antibody.

Step 1: Define your goal and antibody format

Start by deciding what the antibody will be used for:

• Research reagent for detection (WB, ELISA, IF)
• Functional assays (neutralization, receptor activation/inhibition)
• Screening or early discovery candidate

Then choose format:

• Standard IgG
• Fc-silent or Fc-engineered variant
• Fab/scFv for special assay needs
• Fusion antibodies (as required)

Step 2: Confirm sequences and cloning strategy

A typical sequence package includes:

• Heavy chain variable region
• Light chain variable region
• Selected constant regions
• Secretion signals

Good design supports correct assembly and secretion.

Step 3: Choose transient or stable expression

• Transient for fast screening
• Stable for longer-term supply

Step 4: Transfect CHO cells and run the expression culture

CHO cells are transfected, then cultured under controlled conditions.

Well-run CHO workflows often use:

• Serum-free media
• Controlled feeding strategies
• Consistent harvest timing

Step 5: Harvest supernatant

Most recombinant antibodies are secreted into the media, making harvest straightforward.

Step 6: Purify the antibody

For IgG, Protein A affinity purification is a common first capture step, often followed by:

• Buffer exchange
• Polishing steps (as needed)
• Optional aggregation control (SEC)

Step 7: QC and functional confirmation

Typical checks include:

• Purity (SDS-PAGE)
• Aggregation (SEC-HPLC or equivalent)
• Concentration and yield
• Binding confirmation (ELISA, BLI/SPR)

This is the “confidence step”: it confirms that your recombinant expression delivered the product you intended.

Recombinant proteins beyond antibodies: how CHO platforms can help

Although CHO is best known for antibody production, it can also produce many other recombinant proteins, especially when mammalian processing improves function or stability.

Examples include:

• Fc-fusion proteins
• Secreted receptors and ligands
• Complex glycoproteins
• Certain antigens that benefit from mammalian expression

If your project needs both antibodies and related recombinant proteins, using compatible expression logic can reduce variability and make interpretation cleaner.

How BetalifeSci fits naturally into this workflow

CHO-based production platforms and antibody expression services are part of the “make” side of the workflow. The “use and validate” side often depends on dependable research reagents—targets, antigens, enzymes, and antibodies for confirming results.

BetalifeSci (https://www.betalifesci.com/) offers a broad catalog of recombinant proteins and related life science reagents that can support:

• Assay development and validation (e.g., confirm antibody binding against recombinant antigen)
• Positive controls and standards for reproducible results
• Pathway research where multiple recombinant proteins are needed across experiments

In many projects, teams combine:

• CHO-based recombinant expression (in-house or via a specialist like Evitria AG)
• A consistent research supplier like BetalifeSci for supporting reagents

This combination can make your antibody program feel smoother end-to-end: produce what’s unique (your antibody sequence) and source what’s standardized (validated recombinant proteins and research reagents).

Best practices for successful CHO recombinant expression

Design with the basic antibody structure in mind

Because the basic antibody structure includes heavy + light chains and a defined Fc, confirm:

• You selected the right constant region for the application
• Your signal peptides support secretion
• Your construct design matches the desired antibody format

Start with a “small but informative” pilot.

A pilot run helps you confirm:

• The expression level is sufficient
• Purification behaves as expected
• Binding is preserved

A good pilot can save time and accelerate decision-making.

Match QC to how the antibody will be used.

• For routine assays: purity + binding may be enough
• For sensitive functional assays: add aggregation checks and orthogonal binding confirmation
• For development-like workflows: include broader analytics as needed

Keep conditions consistent

Consistency improves reproducibility:

• Use standardized buffers
• Keep the wash and purification steps stable
• Document key parameters (especially if multiple variants are compared)

Choose the right partner when speed and reliability matter.

When timelines are tight or variants are many, working with an experienced provider like evitria AG can be an efficient way to keep progress moving while maintaining quality.

Conclusion

CHO-based Recombinant expression offers a reliable path to sequence-defined antibodies that perform consistently in real experiments. By understanding Antibody Basics—including the basic antibody structure and the basic structure of antibodies—you can choose formats and constructs that match your goals from the start. And by leveraging CHO cells for expression, you benefit from mammalian folding, secretion, and scalable workflows that support both early screening and more advanced production needs.

Whether you build the capability internally or work with a CHO specialist like evitria AG, pairing expression with strong validation resources (such as the recombinant protein and antibody tools available at BetalifeSci) helps you move forward with confidence and clarity—turning sequence designs into dependable scientific results.

FAQs

What are CHO cells used for in recombinant expression?

CHO cells are widely used for the Recombinant expression of antibodies and other proteins because they support mammalian folding, secretion, and post-translational modifications.

Why choose a recombinant expression for an antibody?

Recombinant expression produces an Antibody from a defined sequence, improving reproducibility, enabling engineering, and supporting consistent validation over time.

What is the basic structure of an antibody?

The basic structure of an antibody typically refers to the IgG architecture: two heavy chains and two light chains forming a Y shape, with variable regions for binding and an Fc region for stability and function.

Can CHO cells produce recombinant proteins other than antibodies?

Yes—CHO cells can produce many recombinant proteins, especially those that benefit from mammalian processing or secretion.

When does it make sense to work with Evitria AG?

If you want a streamlined CHO-based antibody production workflow—especially for transient expression and fast delivery—Evitria AG is often considered a specialist partner in this space.

Where does BetalifeSci fit in antibody projects?

BetalifeSci can support the validation side of your workflow by supplying recombinant proteins, antigens, and research reagents that help confirm binding, build assays, and keep experiments consistent.